The Enterprise Value as of December 2025 (TTM) for Diamyd Medical AB (publ) (DMYD-B.ST) is 1.08B

According to Diamyd Medical AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 1.08B. This represents a change of 1.88% compared to the average of 1.06B of the last 4 quarters.

Diamyd Medical AB (publ) (DMYD-B.ST) Historical Enterprise Value (quarterly & annually)

How has DMYD-B.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Diamyd Medical AB (publ) over the last ten years is 1.04B. The current 1.08B Enterprise Value has changed 10.34% with respect to the historical average. Over the past ten years (40 quarters), DMYD-B.ST's Enterprise Value was at its highest in in the August 2020 quarter at 2.76B. The Enterprise Value was at its lowest in in the August 2017 quarter at 32.78M.

Diamyd Medical AB (publ) (DMYD-B.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Diamyd Medical AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Diamyd Medical AB (publ) (DMYD-B.ST) Average Enterprise Value

How has DMYD-B.ST Enterprise Value performed in the past?

The current Enterprise Value of Diamyd Medical AB (publ) (DMYD-B.ST) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Diamyd Medical AB (publ) (DMYD-B.ST) Enterprise Value vs. Peers

How is DMYD-B.ST’s Enterprise Value compared to its peers?

Diamyd Medical AB (publ)’s Enterprise Value is greater than Oncopeptides AB (publ) (993.88M), greater than SynAct Pharma AB (1.01B), less than Genovis AB (publ.) (1.27B), less than BICO Group AB (publ) (2.09B), greater than Cantargia AB (publ) (688.87M), greater than Xspray Pharma AB (publ) (1.05B), greater than OssDsign AB (publ) (1.06B), greater than Infant Bacterial Therapeutics AB (publ) (458.31M), less than Egetis Therapeutics AB (publ) (1.79B), less than BioInvent International AB (publ) (1.43B),

Build a custom stock screener for Diamyd Medical AB (publ) (DMYD-B.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Diamyd Medical AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Diamyd Medical AB (publ) (DMYD-B.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Diamyd Medical AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.